Rules change for drug patent term extensions
Japan's IP High Court is advocating new rules on when patent term extensions for pharmaceuticals should be granted. Shintaro Yamada of Shiga International Patent Office explains what they mean in practice
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
